[
  {
    "ts": null,
    "headline": "ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards?",
    "summary": "ANIP's rising Cortrophin Gel sales and new rare disease products, along with generic and other segments, could power another earnings beat this quarter.",
    "url": "https://finnhub.io/api/news?id=1285365c78356a5f4ebf735bda0b6f6b78f878e01715b916c3d3c7bb7a52911d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761583440,
      "headline": "ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards?",
      "id": 137231272,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "ANIP's rising Cortrophin Gel sales and new rare disease products, along with generic and other segments, could power another earnings beat this quarter.",
      "url": "https://finnhub.io/api/news?id=1285365c78356a5f4ebf735bda0b6f6b78f878e01715b916c3d3c7bb7a52911d"
    }
  },
  {
    "ts": null,
    "headline": "Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System",
    "summary": "WILMINGTON, Del. & CINCINNATI, October 27, 2025--Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System",
    "url": "https://finnhub.io/api/news?id=2a703f4d889634398b8f33664ffd5116b595c98eed5b3e080fea8fb924a85e02",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761564600,
      "headline": "Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System",
      "id": 137229219,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "WILMINGTON, Del. & CINCINNATI, October 27, 2025--Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System",
      "url": "https://finnhub.io/api/news?id=2a703f4d889634398b8f33664ffd5116b595c98eed5b3e080fea8fb924a85e02"
    }
  },
  {
    "ts": null,
    "headline": "What To Expect From Incyte’s (INCY) Q3 Earnings",
    "summary": "Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting earnings this Tuesday morning. Here’s what you need to know.",
    "url": "https://finnhub.io/api/news?id=becbf42786d3dc35949dd67b20976c11833a9679a55795bdb72d8eaeff14f0b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761534765,
      "headline": "What To Expect From Incyte’s (INCY) Q3 Earnings",
      "id": 137218531,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting earnings this Tuesday morning. Here’s what you need to know.",
      "url": "https://finnhub.io/api/news?id=becbf42786d3dc35949dd67b20976c11833a9679a55795bdb72d8eaeff14f0b5"
    }
  }
]